Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Incretin- market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Incretin-market, defines the market attractiveness level of Incretin- market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Incretin- industry, describes the types of Incretin- market, the applications of major players and the market size, and deeply analyzes the current situation of the global Incretin- market and the development prospects and opportunities of Incretin- industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Incretin- market in Chapter 13.
By Player:
Novartis
Merck
GlaxoSmithKline
AstraZeneca
Takeda Pharmaceutical
Boehringer Ingelheim
Johnson & Johnson
Sanofi
Eli Lilly
By Type:
by Drug Types
Peptide-1 Receptor (GLP-1) Agonists
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
by Rormulation
Oral Drugs
Injectable Drugs
By End-User:
Drug Store
Independent Pharmacies
Hospital Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Incretin- Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Incretin- Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Incretin- Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Incretin- Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Incretin- Market Analysis and Outlook to 2022
-
7.1 Global Incretin- Consumption (2017-2022)
-
7.2 United States Incretin- Consumption (2017-2022)
-
7.3 Europe Incretin- Consumption (2017-2022)
-
7.4 China Incretin- Consumption (2017-2022)
-
7.5 Japan Incretin- Consumption (2017-2022)
-
7.6 India Incretin- Consumption (2017-2022)
-
7.7 South Korea Incretin- Consumption (2017-2022)
8 Region and Country-wise Incretin- Market Analysis and Outlook to 2028
-
8.1 Global Incretin- Consumption Forecast (2022-2028)
-
8.2 United States Incretin- Consumption Forecast (2022-2028)
-
8.3 Europe Incretin- Consumption Forecast (2022-2028)
-
8.4 China Incretin- Consumption Forecast (2022-2028)
-
8.5 Japan Incretin- Consumption Forecast (2022-2028)
-
8.6 India Incretin- Consumption Forecast (2022-2028)
-
8.7 South Korea Incretin- Consumption Forecast (2022-2028)
9 Global Incretin- Market Outlook by Types and Applications to 2022
-
9.1 Global Incretin- Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global by Drug Types Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Peptide-1 Receptor (GLP-1) Agonists Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global by Rormulation Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Oral Drugs Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Injectable Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Incretin- Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Drug Store Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Independent Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
10 Global Incretin- Market Outlook by Types and Applications to 2028
-
10.1 Global Incretin- Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global by Drug Types Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Peptide-1 Receptor (GLP-1) Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global by Rormulation Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Oral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Incretin- Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Drug Store Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Independent Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global Incretin- Import and Export Analysis (Top 5 Countries)
-
11.1 Global Incretin- Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Incretin- Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Incretin- Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Incretin- Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Incretin- Product and Service
-
14.2 Merck
-
14.2.1 Merck Company Details
-
14.2.2 Merck Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck Incretin- Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Incretin- Product and Service
-
14.4 AstraZeneca
-
14.4.1 AstraZeneca Company Details
-
14.4.2 AstraZeneca Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AstraZeneca Incretin- Product and Service
-
14.5 Takeda Pharmaceutical
-
14.5.1 Takeda Pharmaceutical Company Details
-
14.5.2 Takeda Pharmaceutical Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Takeda Pharmaceutical Incretin- Product and Service
-
14.6 Boehringer Ingelheim
-
14.6.1 Boehringer Ingelheim Company Details
-
14.6.2 Boehringer Ingelheim Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Boehringer Ingelheim Incretin- Product and Service
-
14.7 Johnson & Johnson
-
14.7.1 Johnson & Johnson Company Details
-
14.7.2 Johnson & Johnson Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Johnson & Johnson Incretin- Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Incretin- Product and Service
-
14.9 Eli Lilly
-
14.9.1 Eli Lilly Company Details
-
14.9.2 Eli Lilly Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Eli Lilly Incretin- Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Incretin-
-
Figure Incretin- Picture
-
Table Global Incretin- Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Incretin- Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Incretin- Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Incretin- Consumption by Country (2017-2022)
-
Figure United States Incretin- Consumption and Growth Rate (2017-2022)
-
Table Europe Incretin- Consumption and Growth Rate (2017-2022)
-
Figure China Incretin- Consumption and Growth Rate (2017-2022)
-
Figure Japan Incretin- Consumption and Growth Rate (2017-2022)
-
Figure India Incretin- Consumption and Growth Rate (2017-2022)
-
Figure South Korea Incretin- Consumption and Growth Rate (2017-2022)
-
Figure Global Incretin- Consumption Forecast by Country (2022-2028)
-
Figure United States Incretin- Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Incretin- Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Incretin- Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Incretin- Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Incretin- Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Incretin- Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global by Drug Types Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide-1 Receptor (GLP-1) Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global by Rormulation Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Store Consumption and Growth Rate (2017-2022)
-
Figure Global Independent Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global by Drug Types Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peptide-1 Receptor (GLP-1) Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global by Rormulation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Store Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Independent Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Incretin- Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Incretin- Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Incretin- Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Incretin- Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Incretin- Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Incretin- Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Incretin- Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Incretin- Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Incretin- Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Incretin- Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Incretin- Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Incretin- Product and Service
-
